6 recruiting. 6 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Recruiting 6 |
| Phase 2 | 3 | Recruiting 3 |
Follow Endothelial Dysfunction: new trials by email Literature Review of Endothelial Dysfunction trials Research Report on Endothelial Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD TB-500, Placebo - Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction | Phase 1 / Phase 2 | Recruiting | Hudson Biotech | 80 | 2026-02-05 | 2026-11-12 |
| Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia Drug Lowering Cerebral Blood Flow (CBF) and Normoxia Sleep, Drug Lowering CBF and Intermittent Hypoxia Sleep, Placebo and Normoxia Sleep - Obstructive Sleep Apnea of Adult, Hypoxia, Brain | Phase 1 / Phase 2 | Recruiting | University of Calgary | 12 | 2023-01-01 | 2026-05-01 |
| Study to Assess Safety and Tolerability of Multiple Doses of EO2002 EO2002, Ripasudil - Corneal Edema, Corneal Endothelial Dystrophy | Phase 1 | Recruiting | Asociación para Evitar la Ceguera en México | 12 | 2022-11-08 | 2025-12-08 |
| B-Complex: A Nutraceutical SANS Countermeasure Vitamin B-Complex Supplement - Optic Disc Edema, Endothelial Dysfunction | Phase 1 | Recruiting | National Aeronautics and Space Administration (NASA) | 16 | 2022-08-01 | 2026-11-12 |
| MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes Metformin Hcl 1000Mg Tab, Aminohippurate Sodium 20 % Injection, Iohexol 300 Mg/mL Injectable Solution - Type 1 Diabetes, Diabetic Kidney Disease | Phase 1 | Recruiting | Kalie Tommerdahl | 60 | 2022-07-01 | 2025-06-13 |
| Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans Galantamine, Placebo, TENS 7000 - Endothelial Dysfunction | Phase 1 / Phase 2 | Recruiting | Vanderbilt University Medical Center | 160 | 2021-12-20 | 2026-05-18 |
Atherosclerosis (1) · Cardiovascular Diseases (1) · Corneal Dystrophy, Posterior Polymorphous, 1 (1) · Corneal Edema (1) · Diabetes Mellitus, Type 1 (1) · Diabetic Nephropathies (1) · Fuchs' Endothelial Dystrophy (1) · Hypoxia, Brain (1) · Inflammation (1) · Insulin Resistance (1) · Papilledema (1) · Sleep Apnea Syndromes (1) · Sleep Wake Disorders (1) · Stroke (1)
Cardiovascular Diseases (2) · Eye Diseases (2) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Vascular Diseases (2) · Apnea (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Autoimmune Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Corneal Diseases (1) · Corneal Dystrophies, Hereditary (1)
Cerebrovascular Circulation (1) · Core Binding Factors (1) · Galantamine (1) · Injections (1) · Iohexol (1) · K-115 (1) · Metformin (1) · Sugars (1) · p-Aminohippuric Acid (1)
Asociación para Evitar la Ceguera en México (1) · Hudson Biotech (1) · Kalie Tommerdahl (1) · National Aeronautics and Space Administration (NASA) (1) · University of Calgary (1) · Vanderbilt University Medical Center (1)
United States (3) · Canada (1) · China (1) · Mexico (1)
Cyndya Shibao, MD (1) · Sara R Zwart, PhD (1) · Valeria Sanchez Huerta, MD (1)
K23HL159292 (1)